Scholarly article on 2,2,4,4,5-pentamethyl-5-phenyl-oxazolidine 41850-39-9 from Journal of the American Chemical Society p. 3072 - 3074

DOI: 10.1021/ja00790a087

Source and publish data:

Journal of the American Chemical Society p. 3072 - 3074 (1973)

Update date:2022-08-05

Topics:

Authors:

Baum,A.A.

Karnischky,L.A.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00790a087

Full text of DOI:10.1021/ja00790a087

Products guided by the article

Product name:2,2,4,4,5-pentamethyl-5-phenyl-oxazolidine

Cas No:41850-39-9

R&D Labs maybe for 41850-39-9

MedicalChem(Yancheng)Manuf.Co.,Ltd.

Contact:+86-515-84383366

Address:Touzeng BinHai, YanCheng City, JiangSu Province, China
Shandong Jusage Technology Co.,Ltd.

Contact:86-13406130167

Address:No.20,North Ride No.9 Road, Guangrao Economic Development Zone, Shandong Province
Zhengzhou HQ Material Co.,Ltd

Contact:+86-371-67759225

Address:No.32, Jinsuo Road, High-tech Zone
TAIXING BEST NEW MATERIALS CO., LTD

Contact:0523-87998158;

Address:No.18 Zhonggang Road，Taixing City ，Jiangsu , China
puyang hongda shengdao new material co.,ltd.

Contact:+86-393- 4896278

Address:No.29 East Zhongyuan Road

Relevant to this article

Enamino ester reduction: A short enantioselective route to pyrrolizidine and indolizidine alkaloids. Synthesis of (+)-laburnine, (+)-tashiromine, and (-)-isoretronecanol

Doi:10.1021/jo982169p
(1999)
Synthesis and evaluation of 2-substituted 8-hydroxyadenines as potent interferon inducers with improved oral bioavailabilities

Doi:10.1016/j.bmc.2003.12.008
(2004)
Ultrabright benzoselenadiazole-based semiconducting polymer dots for specific cellular imaging

Doi:10.1039/c3ra42565g
(2013)
Discovery of a new class of p38 kinase inhibitors

Doi:10.1016/S0960-894X(00)00270-5
(2000)
Regio- and stereoselective synthesis of oligosaccharides with acetobromolactose and acetobromomaltose as glycosyl donors via orthoester intermediates

Doi:10.1080/07328309908544009
(1999)
Non-peptide α_vβ₃ antagonists. Part 7: 3-Substituted tetrahydro-[1,8]naphthyridine derivatives

Doi:10.1016/j.bmcl.2003.11.036
(2004)

Article Doi

DOI: 10.1021/ja00790a087